J&J to pump another $13B into its MedTech business with Shockwave deal

sport2024-05-21 14:33:499532

Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.

The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.

The deal has already been approved by the boards of directors from both companies.

Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.

Shockwave’s technology is used to treat coronary artery and peripheral artery disease.

The company’s revenue jumped 49% last year to $730 million.

Address of this article:http://armenia.tom-paine.com/content-48b299874.html

Popular

College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at

Roundup: Foreign Leaders, Scholars Mourn Former Chinese Leader Jiang

Inner Mongolia advances Three

Peng Liyuan Meets with Indonesian First Lady

Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored

Xi Sends Congratulatory Letter to TWAS 16th General Conference, 30th General Meeting

Xi, DR Congo President Exchange Congratulations on 50th Anniversary of Normalization of China

Xi Says China Committed to Building Asia

LINKS